Abstract
There is limited evidence whether women benefit to the same degree as men from treatment of myocardial infarction with percutaneous coronary intervention (PCI) when compared to fibrinolysis. This study compares health-related quality of life (HRQoL) outcomes for men and women randomized to primary PCI and fibrinolysis.
| Original language | English |
|---|---|
| Journal | European Journal of Cardiovascular Prevention & Rehabilitation |
| Volume | 14 |
| Issue number | 1 |
| Pages (from-to) | 37-43 |
| Number of pages | 7 |
| ISSN | 1741-8267 |
| DOIs | |
| Publication status | Published - 2007 |
Keywords
- Adult
- Aged
- Aged, 80 and over
- Angioplasty, Balloon, Coronary
- Female
- Fibrinolytic Agents
- Humans
- Male
- Middle Aged
- Myocardial Infarction
- Quality of Life
- Risk Assessment
- Sex Factors
- Sickness Impact Profile
- Thrombolytic Therapy
- Tissue Plasminogen Activator
- Treatment Outcome
Fingerprint
Dive into the research topics of 'Gender differences in health-related quality of life following ST-elevation myocardial infarction: women and men do not benefit from primary percutaneous coronary intervention to the same degree'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS